Triple negative breast cancer (TNBC) is characterized by its lack of expression of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2, and accounts for ~10–15% of breast cancers [189]. This evidence concerns the gene ESR1 and breast cancer.